Skip to main content



These policies highlight our responsibility to patients, employees, the environment and local communities. They allow us to integrate corporate responsibility into efforts across our business landscape and employee experience. 

Woman sitting on couch and smiling
Pipet filling Erlenmeyer Flask with red liquid

Our policies

Icon - Healthcare - Vaccine

Access to medicine

We’re committed to optimizing the impact of mRNA vaccines and therapeutics through fair pricing and access for all.

Icon - Humanity - Personal Chart

Human rights

As a company at the forefront of developing medicines for patients across the world, we have an obligation to purposefully uphold human rights.

Icon - Business - Paper

Political engagement policy

We do not make direct contributions to political campaigns or candidates, and are committed to transparency on our engagement with trade associations and other advocacy organizations.

Icon - Business - Certificate

Code of business conduct & ethics

Ensuring all employees act ethically and legally in their business decisions and day-to-day duties is crucial to carrying out our mission.

Icon - Business - Notebooks

Corporate governance guidelines

We believe sound governance practices and policies are important to our success as a company and to obtaining the trust of our stakeholders.

Icon - Business - Network

2018 Citizenship framework

Our 2018 Corporate Social Responsibility (CSR) whitepaper, which laid out the framework for the core focus areas of our CSR program.

Icon - Business - Personal Chart

CEO action for diversity & inclusion pledge

We’ve pledged to act on supporting more inclusive workplaces because we know that success is rooted in diverse viewpoints.

Icon - Business - Name Tag

U.S. employee benefits

Moderna team members drive our advancements toward bringing innovative medicines to patients. Our commitment to them is rooted in an inclusive environment that fosters well-being.

Icon - Business - Notebook

Government funding and vaccine access

Learn more about how we have approached access and pricing for our COVID-19 vaccine, including as a result of government funding.